Skip to main content
Caplight Logo









Medgene Labs

Medgene Labs

Private
Brookings, South DakotaHealthcare & Life Scienceshttps://medgenelabs.com/

Last Round

Grant

Sep 1, 2024

Total Funding Raised

$1.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Medgene Labs is an animal health company that develops and manufactures innovative veterinary vaccines using a proprietary platform technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

veterinary vaccinesanimal healthlivestock vaccinesprescription platformbioinformaticscustom vaccinesherd healthimmunological servicesfield diagnosticsbiologicsanimal biotechvaccine developmentagtechvet medanimal pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Medgene Labs Comparables

Compare Medgene Labs with similar companies based on industry and business-model similarity.

Medgene Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cambridge Technologies
85%
Vacci-Vet Inc.
82%
SAN Group
81%

Medgene Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 1, 2024
GrantMay 23, 2023
SeedSep 30, 2013

Key People

Founding team and executive leadership

Mark Luecke

CEO

Executive Team

Alan Young

Chief Technology Officer

Executive Team

Larry Thornton

CFO

Executive Team

Medgene Labs Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors increased 40% MoM.

  • Jun 1, 2025

    Monthly visitors increased 50% MoM to 2.1K.

Recent news

Latest coverage and updates

  • launchesSep 24, 2026

    Medgene launched platform vaccine targeting Theileria on Sep 24th '26.

Medgene Labs Filings

Explore SEC and related filing metadata, where available.

Medgene Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Medgene Labs's valuation, stock price, and market status.

Is Medgene Labs a public or private company?

Medgene Labs is a private company.

What is the current stock price of Medgene Labs?

Medgene Labs is a private company with no public stock price. No recent secondary market data is available.

How much is Medgene Labs worth (valuation)?

Valuation information for Medgene Labs is not publicly available.

Can I buy Medgene Labs stock?

Medgene Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Medgene Labs's last funding round?

Medgene Labs's most recent funding round was Grant on September 1, 2024.

Who are the main investors in Medgene Labs?

Key investors in Medgene Labs include National Institute of Food and Agriculture, U.S. Department of Agriculture.

Will Medgene Labs IPO soon?

No public IPO plans have been announced for Medgene Labs.

How can I track Medgene Labs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medgene Labs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBrookings, South Dakota
Employee Range62
Year Founded2011
Last FundingSep 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?